Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

3SBio Ups its Take-Private Offer as Opposition Rises

publication date: Apr 23, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
3SBio received a much-higher offer from the consortium that wants to take the company private. The offer now stands at $16.70 per ADS, up from $15.40. Rumors have surfaced that other bidders would bid up to $20 per ADS. But 3SBio effectively quashed the offers by threatening that the majority of senior management would leave the company unless the winning consortium includes 3SBio’s Chairman/CEO, Jing Liu. Dr. Liu is the man behind the original offer and the now-increased bid. More details....

Stock Symbol: (NSDQ: SSRX)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...